CELCUITY INC. APIC, Share-based Payment Arrangement, ESPP, Increase for Cost Recognition
CELCUITY INC. (CELC) reported APIC, Share-based Payment Arrangement, ESPP, Increase for Cost Recognition of $464.65 thousand for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-07.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital › APIC, Share-Based Payment Arrangement, Increase for Cost Recognition
us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition · last filed 2020-05-07
- CELCUITY INC. apic, share-based payment arrangement, espp, increase for cost recognition for the quarter ending 2020-03-31 was $464.65K, a 151.64% increase year-over-year.
- CELCUITY INC. apic, share-based payment arrangement, espp, increase for cost recognition for the quarter ending 2019-09-30 was $218.91K, a 0.86% decline year-over-year.
- CELCUITY INC. apic, share-based payment arrangement, espp, increase for cost recognition for the quarter ending 2019-06-30 was $125.63K, a 16.99% decline year-over-year.
- CELCUITY INC. apic, share-based payment arrangement, espp, increase for cost recognition for the quarter ending 2019-03-31 was $184.65K, a 17.60% increase year-over-year.
- CELCUITY INC. apic, share-based payment arrangement, espp, increase for cost recognition for fiscal 2019 was $1.04M, a 10.92% decline from fiscal 2018.
- CELCUITY INC. apic, share-based payment arrangement, espp, increase for cost recognition for fiscal 2018 was $1.17M, a 72.52% increase from fiscal 2017.
- CELCUITY INC. apic, share-based payment arrangement, espp, increase for cost recognition for fiscal 2017 was $677.37K, a 379.02% increase from fiscal 2016.
- CELCUITY INC. apic, share-based payment arrangement, espp, increase for cost recognition for fiscal 2016 was $141.41K.
| Period end | APIC, Share-based Payment Arrangement, ESPP, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, ESPP, Increase for Cost Recognition 3 month as first filed | APIC, Share-based Payment Arrangement, ESPP, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, ESPP, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, ESPP, Increase for Cost Recognition 12 month | APIC, Share-based Payment Arrangement, ESPP, Increase for Cost Recognition 12 month as first filed |
|---|---|---|---|---|---|---|
| 2020-03-31 | $464.65K 10-Q · filed 2020-05-07 | |||||
| 2019-12-31 | $1.04M 10-K · filed 2020-03-13 | |||||
| 2019-09-30 | $218.91K 10-Q · filed 2019-11-07 | $344.55K derived: sum of 2 quarters · filed 2019-11-07 | $529.19K derived: sum of 3 quarters · filed 2020-05-07 | |||
| 2019-06-30 | $125.63K 10-Q · filed 2019-11-07 | $310.28K derived: sum of 2 quarters · filed 2020-05-07 | ||||
| 2019-03-31 | $184.65K 10-Q · filed 2020-05-07 | $120.99K 10-Q · filed 2019-05-07 | ||||
| 2018-12-31 | $1.17M 10-K · filed 2020-03-13 | $1.02M 10-K · filed 2019-03-01 | ||||
| 2018-09-30 | $220.81K 10-Q · filed 2019-11-07 | $372.16K derived: sum of 2 quarters · filed 2019-11-07 | $529.17K derived: sum of 3 quarters · filed 2019-11-07 | $777.64K derived: sum of 4 quarters · filed 2019-11-07 | ||
| 2018-06-30 | $151.35K 10-Q · filed 2019-11-07 | $308.36K derived: sum of 2 quarters · filed 2019-11-07 | $556.83K derived: sum of 3 quarters · filed 2019-11-07 | |||
| 2018-03-31 | $157.01K 10-Q · filed 2019-11-07 | $405.48K derived: sum of 2 quarters · filed 2019-11-07 | ||||
| 2017-12-31 | $248.47K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $677.37K 10-K · filed 2019-03-01 | ||||
| 2017-09-30 | $428.90K 10-Q · filed 2017-12-01 | |||||
| 2016-12-31 | $141.41K 10-K · filed 2018-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |